CClinicalTrials.gg
Not yet recruitingNCT07450079Updated Mar 4, 2026

Characterising Sleep Disorders in Children With Tourette Syndrome

An observational study in Tourette Syndrome, sponsored by Steffi Baker. Not yet recruiting. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Steffi Baker · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
34
Ages
6 Years to 17 Years
Sex
All
01

Study summary

Healthy sleep is essential for a young person's growth, development, and wellbeing. It is estimated that up to 80% of young people with Tourette Syndrome experience sleep difficulties. Tourette Syndrome is a neurological condition that causes sudden, unwanted, and repeated motor movements and vocal sounds, known as tics. Previous studies have shown that children with this condition have poorer sleep quality, specifically increased awakenings and difficulties falling or staying asleep. These challenges highlight the need to better understand sleep problems in young people with Tourette Syndrome.

This study will assess whether children's tics affect their sleep quality by measuring how often tics occur during sleep and how severe they are. To do this, the investigators will use a new Tic index to measure the impact of tics during an overnight sleep study. A watch like device that tracks movement and light levels will also be employed to help estimate when someone is asleep or awake. Together, these measures enable a clear comparison between the sleep of children with Tourette Syndrome and those without. Children will also complete a questionnaire to gain insights into their personal experiences and how they perceive tics to influence their sleep.

The specific objectives include:

  1. Compare the sleep patterns of children with Tourette syndrome (TS) to those of children without TS, to see whether tics are linked to any differences in sleep.
  2. Assess how accurately the tic measurements identify tics during sleep, to see whether they could be useful in future research.
  3. Explore whether tic activity changes during different stages of sleep in children with TS.
  4. Look at how the results from sleep recordings (such as movement monitors and tic measurements) relate to questionnaire responses about sleep and tics.

Results from this study can be used to support future research that continues to improve the management and treatment of sleep problems in Tourette Syndrome children.

Read the detailed description

Gilles de la Tourette Syndrome (TS) is a neurobehavioural condition characterised by persistent motor and vocal tics, with symptom onset typically around the age of six. Tics are described as sudden, rapid, and repetitive involuntary movements. While the core clinical features of TS are well established, the effects of TS on sleep in children remain poorly understood.

Difficulties with sleep are frequently reported in children, including trouble initiating sleep, frequent night-time awakenings, decreased sleep efficiency, excessive sleep duration, and parasomnias such as night terrors and sleepwalking. Increasing evidence suggests that sleep problems are highly common among children with TS, with reported rates of sleep disorders ranging widely from 9% to 80%. The most frequent sleep disorders reported in this population include insomnia, excessive daytime sleepiness, and disorders of arousal. Beyond the diagnosis of specific sleep disorders, studies have shown that children with TS most commonly exhibit prolonged sleep onset and reduced total sleep efficiency compared to typically developing peers. Considering sleep plays a critical role in daytime functioning and is predictive of neurodevelopment, cognitive performance, and emotional wellbeing, understanding sleep problems in children with TS is of vital importance.

Previous studies of sleep problems in children with TS have primarily used a single objective sleep study. The primary method of sleep assessment is polysomnography (PSG), a sleep study that measures brain activity, heart activity, eye movements, muscle tone, limb movements, and respiratory patterns. One study using PSG found that children with TS had reduced sleep efficiency and increased arousals compared to healthy controls. Similarly, another study that utilised a different sleep study named actigraphy, a watch that tracks movement and light exposure to estimate sleep and wake, also found low sleep efficiency and a higher fragmentation index in children with TS. However, the heightened arousals observed in these studies were scored according to standard criteria for all sleep study analyses. Thus, these arousals cannot be directly attributed to tics, as they represent a general measure of wakefulness during sleep. Moreover, actigraphy has demonstrated low specificity for detecting wakefulness during sleep, although it provides a long-term and naturalistic representation of an individual's sleep. This contrasts with PSG, which may be influenced by the "first night effect", where sleep is altered by the unfamiliar sleep lab environment. Therefore, integrating findings from both PSG and actigraphy will provide a more thorough assessment of sleep in this population.

Furthermore, these objective methods of assessing sleep do not capture how the child or their parents perceive sleep quality and its effect on everyday life. Parent-report studies in TS show high rates of reported sleep disturbance and demonstrate that greater tic severity predicts increased sleep problems and worsening daytime functioning. Moreover, research comparing the concordance of objective and subjective measures of sleep has shown a discrepancy. Subjective reports of sleep in children with TS have consistently underestimated night-time awakenings and overestimated total sleep time compared with actigraphy and PSG results. This discrepancy highlights that subjective measures capture perceptual and experiential aspects of sleep that are not captured in physiological recordings, underscoring the value of including targeted subjective measures when investigating sleep problems in TS.

Previous research investigating sleep problems in children with TS has not examined arousals attributable to tics, has relied on a single objective method to assess sleep patterns, and has not combined objective and subjective measures of sleep to provide a comprehensive characterisation of sleep in this population. This highlights a gap in the research with respect to combining objective data from PSG and actigraphy with subjective reports. To address this, the present study will apply novel Tic indices during PSG analysis of children with TS to quantify tic-related sleep disruption, alongside a newly developed Tic in Sleep questionnaire to provide a holistic evaluation of how TS affects sleep and daytime functioning. The investigators will test the hypothesis that children with TS will exhibit poorer sleep quality, both objectively and subjectively, compared to historical control data from healthy children.

Participants This study involves the retrospective analysis of PSG and actigraphy data from children with TS who are already under investigation for sleep problems by the Evelina London Children's Hospital. All participants will have been referred to the sleep service team, known by the Tics and neuro-developmental movements (TandDEM) team, and will meet the diagnostic criteria for TS according to the International Classification of Diseases (ICD-10; F95.2).

Sample size Power analysis to determine sample size was completed using G*Power 3.1.9.6 software.

The Tic in Sleep questionnaire will be completed by TS children only. As no control group will be included, sample size calculation is based on detecting a correlation between questionnaire responses and objective measures (PSG and actigraphy). An a priori power calculation indicated that 29 participants are required to detect a medium effect (ρ = 0.5) with α = 0.05 and 80% power. To allow for incomplete data, 34 children with TS will be recruited for completion of the Tic in Sleep questionnaire.

A sample size of 12-15 participants for retrospective analysis of PSG and actigraphy data is suitable for this part of the study. This will provide sufficient data to examine whether the Tic indices can reliably assess the impact, severity, and frequency of tics on sleep. In the future, this data can be used to calculate proper effect sizes for a larger study employing the Tic indices.

Tic indices PSG and actigraphy studies will be scored using the latest AASM guidelines (Version 3.0). Within the PSG analysis framework, two novel Tic indices will be introduced: one scores tics during sleep (Ts); the other scores tics during sleep that cause arousal (Tsa). The indices will be broken down for each sleep stage (wake, NREM1, NREM2, NREM3, REM). A feature will be added within Embla® RemLogic™ to enable scoring of the Tic indices directly within the software.

Tic in Sleep Questionnaire A purpose-designed Tic in Sleep questionnaire will be created to provide a subjective assessment of sleep in TS children. This will be completed by the participants, with support from parents/guardians to capture both child and parental observations of tic-related influences on sleep quality, dreams, and daytime functioning. Additionally, the questionnaire will collect information on participant comorbidities and medications.

Study Design Assessment of sleep in TS children typically involves a two week actigraphy and an inpatient PSG. As this is a retrospective study, these investigations will have been completed as part of their routine care. Eligible participants will be identified through sleep clinics, and inclusion and exclusion criteria will be reviewed by the research team.

Once consent and assent have been obtained, participants will be invited to complete the Tic in Sleep questionnaire via a Jisc link. PSG and actigraphy data of the selected participants will then be scored using the Tic indices by an AASM certified sleep physiologist

Statistical Analysis Statistical analysis will be performed in SPSS 30.0 (SPSS Inc., Chicago, IL).

An independent samples t-test will be applied to compare TS children's sleep parameters to historical control data from healthy children, as published in the AASM Scoring Manual, Version 3.0 (2023). This test will identify if the difference in their sleep parameters (sleep efficiency, total sleep time, arousal index, etc.) is a real, statistically significant difference or due to random chance.

Tic indices will be calculated as the number of tics per hour, reported as a mean ± standard deviation (SD). A repeated-measures ANOVA will be used to compare the Tic indices between sleep stages and wake within the same participant to identify if, overall, sleep stage makes a difference to the Tic index. If it does, post-hoc tests can be employed, such as a Bonferroni correction.

To directly compare Ts and Tsa within each participant, a paired samples t-test can be used. This will explore if a child generally arouses from tics during sleep, or if they continue to sleep during their tics.

Finally, Cronbach's alpha will determine the internal consistency of responses received from the questionnaire, thus testing the validity of this new Tic in Sleep questionnaire. Descriptive statistics, including means, standard deviations, medians, and percentages, will be used to evaluate specific questionnaire responses.

Research Ethics and Clinical Governance Ethical approval is currently being obtained from the Health Research Authority (HRA) [IRAS:362134, pending], alongside governance approval from GSTT Research and Development (R\&D). Before data collection, approval from the University Ethics Committeettee (EthOS) at Manchester Metropolitan University will be acquired.

Key outcomes and impacts This study aims to validate the newly defined Tic index as an objective measure of sleep disruption in children with TS. Analysis of actigraphy and PSG data will characterise how tics affect sleep architecture, sleep-stage patterns, and overall sleep quality relative to historical control data from healthy children. By combining objective results from actigraphy and PSG with subjective reports from the Tic in Sleep questionnaire, this study will describe the impact, severity, and frequency of tics in sleep and how this relates to the perceived quality of sleep and daytime functioning.

The impact of this research lies in providing the first systematic evidence supporting the Tic index as a direct tool for evaluating tic-related sleep disruption. It will also assess the feasibility of applying the Tic index in future larger-scale studies. Furthermore, this study will enhance our understanding of how tics affect sleep physiology, and how sleep is experienced by children with TS and their parents. Ultimately, this work will contribute to the development of standardised assessment tools that can be used to evaluate sleep disruption and support improved management and treatment of sleep problems in children with TS.

02

Conditions studied

  • Tourette Syndrome

Keywords

  • Tourette Syndrome
  • sleep disturbances
  • tic index
  • arousals
  • polysomnography
  • actigraphy
  • questionnaire
  • tics in sleep
03

In context

Tourette Syndrome

220 studies on the registry are indexed under Tourette Syndrome; 37 are open to participants now.

This study's planned enrollment of 34 is below the median of 60 across 43 observational studies indexed under Tourette Syndrome.

Browse Tourette Syndrome studies →

Lead sponsor

This is the only study on the registry with Steffi Baker as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be between the ages of 6-17. All participants will have been referred to the sleep service team, known by the Tics and neuro-developmental movements (TandDEM) team, and will meet the diagnostic criteria for TS according to the International Classification of Diseases (ICD-10; F95.2).

Inclusion criteria

  • Patients already under investigation by Evelina London Children's Hospital for sleep disturbances
  • Diagnosis of Tourette Syndrome in accordance with the International Classification of Diseases (ICD-10;F95.2)
  • Ages 6-17 at time of recruitment, and not between transition or due to transition to adult services
  • Have had a successful and compliant PSG, ideally within 6 months of recruitment
  • Participants able to understand patient information and can provide informed assent
  • Participants have parent and/or guardian willing to provide informed consent on behalf of the child

Exclusion criteria

Exclusion Criteria:

  • Any physician diagnosed chronic medical condition that could impact their study participation
  • Non-verbal participants without access to appropriate communication support
  • Non-English-speaking participants without access to appropriate translator
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
34 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children with Tourette Syndrome - QOG

    The questionnaire only group (QOG) consist of children with Tourette Syndrome who will only be required to complete the Tic in Sleep questionnaire.

  • Children with Tourette Syndrome - SSQG

    The sleep study and questionnaire group (SSQG) consist of children with Tourette Syndrome whom will undergo retrospective analysis of PSG and actigraphy studies and complete the Tic in sleep questionnaire.

06

What researchers measure

Primary outcomes

  1. Tic index as a measure of sleep quality.

    Tics in sleep (Ts) and tics in sleep that cause arousals (Tsa) will be combined to produce a Tic Index. The Tic index will quantify sleep quality in children with Tourette syndrome. Higher scores will indicate greater impact on sleep quality, thus worse sleep.

    Time frame: Through study completion, on average18 months.

  2. Tic in sleep questionnaire scores

    Responses from the Tic in sleep questionnaire will be scored accordingly based on the reported impact on sleep. Higher scores will indicate greater impact on sleep quality, thus worse sleep.

    Time frame: From receipt of 34 questionnaire responses to study completion, on average 12months.

Secondary outcomes

  1. Apnoea-hypopnoea index (AHI) from PSG

    The AHI will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average 18months.

  2. Total Sleep Time (TST) from PSG

    The TST will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Lower score typically indicates worse sleep.

    Time frame: Through study completion, on average18 months

  3. Sleep Efficiency from PSG

    Sleep efficiency will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Lower score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  4. Sleep Latency from PSG

    The sleep latenccy will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  5. Wake After Sleep Onset (WASO) from PSG

    The WASO will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months

  6. Arousal Index from PSG

    The arousal index will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  7. Periodic Limb Movement Index (PLMI) from PSG

    The PLMI will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  8. Oxygen desaturation index (ODI) from PSG

    The ODI will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  9. Sleep Stage Percentages from PSG

    The sleep stage percentages will be compared in PSG results from children with Tourette Syndrome and data from age-matched historical controls. Sleep staging will be compared with established normative percentages for each sleep stage to determine whether results fall within normal or abnormal ranges.

    Time frame: Through study completion, on average18 months.

  10. Total sleep time (TST) from actigraphy

    The TST will be compared in actigraphy results from children with Tourette Syndrome and data from age-matched historical controls. Lower score typically indicates worse sleep.

    Time frame: Through study completion, on average18 months.

  11. Sleep efficiency from actigraphy

    The sleep efficiency will be compared in actigraphy aresults from children with Tourette Syndrome and data from age-matched historical controls. Lower scores indicate worse sleep.

    Time frame: Through study completion, on average18 months.

  12. Sleep latency from actigraphy

    The sleep latency will be compared in actigraphy results from children with Tourette Syndrome and data from age-matched historical controls. Higher scores indicate worse sleep.

    Time frame: Through study completion, on average18 months.

  13. Fragmentation (number of awakenings) from actigraphy

    Sleep fragmentation will be compared in actigraphy results from children with Tourette Syndrome and data from age-matched historical controls. Higher score indicates worse sleep.

    Time frame: Through study completion, on average18 months.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Rothenberger A, Heinrich H. Co-Occurrence of Tic Disorders and Attention-Deficit/Hyperactivity Disorder-Does It Reflect a Common Neurobiological Background? Biomedicines. 2022 Nov 17;10(11):2950. doi: 10.3390/biomedicines10112950. PubMed 36428518 ↗
  • Keenan L, Bramham J, Dinca M, Coogan AN, Downes M. Sleep and daytime functioning in children with tourette syndrome: A two-week case-control study with actigraphy and cognitive assessments. Sleep Med. 2024 Jan;113:313-327. doi: 10.1016/j.sleep.2023.11.1137. Epub 2023 Dec 9. PubMed 38101103 ↗
  • Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JAG. Sleep Disorders and Sleep Problems in Patients With Tourette Syndrome and Other Tic Disorders: Current Perspectives. Nat Sci Sleep. 2022 Jul 25;14:1313-1331. doi: 10.2147/NSS.S340948. eCollection 2022. PubMed 35915721 ↗
  • Cohrs S, Rasch T, Altmeyer S, Kinkelbur J, Kostanecka T, Rothenberger A, Ruther E, Hajak G. Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):192-7. doi: 10.1136/jnnp.70.2.192. PubMed 11160467 ↗
  • Ghosh D, Rajan PV, Das D, Datta P, Rothner AD, Erenberg G. Sleep disorders in children with Tourette syndrome. Pediatr Neurol. 2014 Jul;51(1):31-5. doi: 10.1016/j.pediatrneurol.2014.03.017. Epub 2014 Mar 27. PubMed 24938137 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07450079
Lead sponsor
Steffi Baker
Collaborators
Guy's and St Thomas' NHS Foundation Trust
Responsible party
Steffi Baker (Trainee Healthcare Scientist, Guy's and St Thomas' NHS Foundation Trust) — Sponsor-investigator
First posted
Mar 4, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Mar 4, 2026

Study contacts

Steffi A Baker, BSc Neuroscience
Contact
steffi.baker1@nhs.net
020 7188 7188
Paul Gringras, MBChB, MRCPCH (UK), MSc
Contact
p.gringras@nhs.net
02071884649

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion